A Patent Review of EZH2 Inhibitors from 2017 and Beyond
EXPERT OPINION ON THERAPEUTIC PATENTS（2023）
Key words
Cancer,Degrader,EZH2 inhibitor,Patent,Tazemetostat
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined